ASND - Ascendis Pharma A S Stock Trading

Ascendis Pharma A/S(NASDAQ: ASND) stock trading, description, contact, officers and directors.

About Ascendis Pharma A/S

Not available

Stock Information

Ascendis Pharma A/S Company Name:

ASND Stock Symbol:

NASDAQ Market:

Ascendis Pharma A/S Website:

Get ASND Alerts

News, Short Squeeze, Breakout and More Instantly...

ASND - Ascendis Pharma A/S Announces Top-Line Results from Week 84 of Its Phase 2 PaTH Forward Trial Demonstrating that TransCon(TM) PTH Provided Durable Benefit and Was Well-Tolerated in Adults with Hypoparathyroidism

–– 58 of the original 59 subjects continue in the open-label extension portion of the Phase 2 trial. –– Phase 3 data for TransCon PTH expected in Q1 2022. COPENHAGEN, Denmark, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND...
ASND - Ascendis Pharma A/S to Participate in the Evercore ISI 4th Annual HealthCONx Conference

COPENHAGEN, Denmark, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company is scheduled to participate in the Evercore ISI 4th Annual HealthCONx Conference. Company executives will participate in a virtual fireside chat hosted by Evercore ISI....
ASND - Ascendis Pharma A/S Receives Positive CHMP Opinion for TransCon(TM) hGH for Patients with Pediatric Growth Hormone Deficiency

– TransCon hGH is a once-weekly prodrug of somatropin designed to reduce the treatment burden for patients with growth hormone deficiency. – Final European Commission decision on TransCon hGH MAA for pediatric growth hormone deficiency expected within 67 da...